大量的研究集中在睡眠呼吸暂停和心血管或心脏问题之间的联系。一些主要发现包括：

睡眠呼吸暂停导致缺氧，由于在呼吸暂停期间尝试呼吸而增加的胸内压力波动，以及交感神经系统的激活 - 所有这些对心血管系统具有许多负面后果。

睡眠呼吸暂停与高血压密切相关，与其他所有相关的高血压危险因素无关。

睡眠呼吸暂停存在于超过30％的高血压患者。

80％的耐药性高血压患者中出现睡眠呼吸暂停。

用CPAP呼吸机治疗可导致临床上显著的血压下降。该下降足以将冠心病事件的风险降低37％，中风风险降低56％。

在患有心力衰竭的睡眠呼吸暂停患者中使用CPAP呼吸机治疗改善左心室功能。

睡眠呼吸暂停常见于心血管疾病患者，发生于50％房颤患者。

睡眠呼吸暂停患者具有增加的与炎症，氧化和血管内皮效应标记物的水平，其与动脉粥样硬化形成相关。当用CPAP呼吸机治疗睡眠呼吸暂停时，这些标记得到改善。

当睡眠呼吸暂停严重时，显著增加心血管事件的风险。用CPAP持续正压呼吸机治疗降低了这种风险。

上述结论参考了以下28篇研究文献，由北京思力普睡眠研究所独家编译，首先发表于思利浦商城www.9sleep.cn和研究所官网www.BSRI.cn，未经允许，请勿转载。

参考文献：

01
Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease.  JAMA 2003;290:1906-14.阻塞性睡眠呼吸暂停：对心脏和血管疾病的影响。
02
Lattimore JD, Celermajer DS, Wilcox I. Obstructive sleep apnea and cardiovascular disease.  J Am Coll Cardiol 2003;41:1429-37. 阻塞性睡眠呼吸暂停和心血管疾病
03
Bradley TD, Floras JS. Sleep apnea and heart failure: Part I: obstructive sleep apnea.  Circulation 2003;107:1671-8. 睡眠呼吸暂停和心力衰竭：第一章节：阻塞性睡眠呼吸暂停。
04
Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up.  Am J Respir Crit Care Med 2002;166:159-165.阻塞性睡眠呼吸暂停的中年男性心血管疾病发病率增加：7年随访。
05
Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension.  N Engl J Med 2000;342:1378-1384. 前瞻性研究睡眠呼吸障碍与高血压之间的关联。
06
Lavie P, Herer P, Hoffstein V. Obstructive sleep apnea syndrome as a risk factor for hypertension: population study.  BMJ 2000;320:479-82. 阻塞性睡眠呼吸暂停综合征作为高血压的危险因素：人口研究。
07
Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, Pickering TG. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study.  JAMA 2000;283:1829-1836. 睡眠呼吸障碍协会，睡眠呼吸暂停和高血压在一个大型社区基础的研究
08
Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Leiby BE, Vela-Bueno A, Kales A. Association of hypertension and sleep-disordered breathing.  Arch Intern Med 2000;160:2289-95. 男性高血压与睡眠呼吸障碍的关联。
09
Sjostrom C, Lindberg E, Elmasry A, Hagg A, Svardsudd K, Janson C. Prevalence of sleep apnoea and snoring in hypertensive men: a population based study.  Thorax 2002;57:602-7.在高血压男性中睡眠呼吸暂停和打鼾的发病率：基于人群的研究。
10
Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, Leung RS, Bradley TD. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension.  J Hypertens 2001;19:2271-7. 在耐药性高血压中无法识别的睡眠呼吸暂停的高发病率。
11
Logan AG, Tkacova R, Perlikowski SM, Leung RS, Tisler A, Floras JS, Bradley TD. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex.  Eur Respir J 2003;21:241-7. 难治性高血压和睡眠呼吸暂停：CPAP睡眠呼吸机对血压和压力反射的作用。
12
Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE, Peter JH. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea.  Circulation 2003;107:68-73. 经鼻连续气道正压通气CPAP睡眠呼吸机治疗对阻塞性睡眠呼吸暂停患者血压的影响。
13
Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, Davies RJ. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial.  Lancet 2002;359:204-10. CPAP睡眠呼吸机对阻塞性睡眠呼吸暂停治疗和亚治疗后的动态血压：一项随机平行试验
14
Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, O'Connor GT, Boland LL, Schwartz JE, Samet JM. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study.  Am J Respir Crit Care Med 2001;163:19-25. 睡眠呼吸障碍和心血管疾病：睡眠心脏健康研究的横断面结果。
15
Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, Ando S, Bradley TD. Cardiovascular effects of continuous positive airway pressure in patients with heart hailure and obstructive sleep apnea.  N Engl J Med 2003;348:1233-1241. 在心力衰竭和阻塞性睡眠呼吸暂停患者中持续气道正压通气睡眠呼吸机的心血管效应。
16
Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF, Giannuzzi P. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure.  Circulation 1999;99:1435-40. 在慢性心力衰竭中的夜间陈施氏呼吸的预后价值
17
Teschler H, Dohring J, Wang YM, Berthon-Jones M. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure.  Am J Respir Crit Care Med 2001;164:614-9. 自适应压力支持伺服通气呼吸机：心力衰竭中陈施氏呼吸的新型治疗
18
Pepperell JC, Maskell NA, Jones DR, Langford-Wiley BA, Crosthwaite N, Stradling JR, Davies RJ. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure.  J Respir Crit Care Med 2003;168:1109-14.自适应伺服通气呼吸机用于心力衰竭陈施氏呼吸的随机对照试验。
19
Topfer V, El-Sebai M, Wessendorf TE, Moraidis I, Teschler H.[ Adaptive servoventilation: effect on Cheyne-Stokes-Respiration and on quality of life  ]Pneumologie 2004;58:28-32.自适应伺服通气呼吸机：对陈施氏呼吸和生活质量的影响
20
Schadlich S, Konigs I, Kalbitz F, Blankenburg T, Busse HJ, Schutte W.[ Cardiac efficiency in patients with Cheyne-Stokes respiration as a result of heart insufficiency during long-term nasal respiratory treatment with adaptive servo ventilation (AutoSet CS)  ]Z Kardiol 2004;93:454-62. 在具有自适应伺服通气的长期经鼻呼吸治疗期间由于心力衰竭的结果，患有陈施氏呼吸患者的心脏效率
21
Philippe C; Stoica-Herman M; Drouot X; Raffestin B; Escourrou P; Hittinger L; Michel P-L; Rouault S; d'Ortho M-P. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period.  Heart 2006;92(3):337-42. 在6个月内心力衰竭的陈施氏呼吸的治疗中，自适应伺服通气呼吸机与持续正气道通气呼吸机的依从性和有效性。 
22
Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, Malouf J, Ammash N, Friedman P, Somers VK. Association of atrial fibrillation and obstructive sleep apnea.  Circulation 2004;110(4):364-7. 房颤和阻塞性睡眠呼吸暂停的关联。
23
Ip MS, Tse HF, Lam B, Tsang KW, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment.  Am J Respir Crit Care Med 2004;169:348-53. 内皮功能阻塞性睡眠呼吸暂停和治疗反应。
24
Ip MSM, Lam B, Chan LY, Zheng L, Tsang KWT, Fung PCW, Lam WK. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure.  Am J Respir Crit Care Med 2000;162:2166–2171. 循环性一氧化氮在阻塞性睡眠呼吸暂停中被抑制，并通过鼻部持续气道正压睡眠呼吸机反转。
25
Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, Somers VK. Elevated C-reactive protein in patients with obstructive sleep apnea.  Circulation 2002;105:2462-4. 阻塞性睡眠呼吸暂停患者C反应蛋白升高。
26
Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients.  Am J Respir Crit Care Med 2002;165:934-9. 增加的粘附分子表达和活性氧物质在睡眠呼吸暂停患者白细胞中的产生。
27
Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.  Lancet 2005;365(9464):1046-53. 长期心血管结果在男性阻塞性睡眠呼吸暂停低通气患者中用或不用持续气道正压通气睡眠呼吸机治疗：一项观察性研究。
28
Doherty LS, Kiely JL, Swan V, McNicholas WT. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome.  Chest 2005;127(6):2076-84. 经鼻连续气道正压通气睡眠呼吸机治疗对睡眠呼吸暂停综合征心血管结局的长期影响。